Literature DB >> 9607905

Cardioprotective effect of succinate against ischemia/reperfusion injury.

M Sakamoto1, K Takeshige, H Yasui, K Tokunaga.   

Abstract

We investigated the protective effects of succinate, which is a respiratory substrate and a potential antioxidant, on myocardial ischemia/reperfusion injury with the whole heart. Isolated rat hearts were loaded with 25-min normothermic global ischemia followed by 30-min reperfusion in a working heart model. Succinate administered either before reperfusion or added to the cardioplegic solution improved the postischemic cardiac function significantly. The hearts arrested with succinate-supplemented cardioplegic solution replenished high-energy phosphates and maintained the total adenine nucleotides during the reperfusion period, whereas those arrested with succinate-nonsupplemented cardioplegic solution replenished the high-energy phosphates less, and also lost total adenine nucleotides during that period. We thus conclude that succinate administered before reperfusion may decrease the degree of mitochondrial damage during reperfusion and thereby reduce the amount of myocardial ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607905     DOI: 10.1007/s005950050177

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury.

Authors:  Javier A Sala-Mercado; Joseph Wider; Vishnu Vardhan Reddy Undyala; Salik Jahania; Wonsuk Yoo; Robert M Mentzer; Roberta A Gottlieb; Karin Przyklenk
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

Review 2.  The role of succinate and ROS in reperfusion injury - A critical appraisal.

Authors:  Tatyana N Andrienko; Philippe Pasdois; Gonçalo C Pereira; Matthew J Ovens; Andrew P Halestrap
Journal:  J Mol Cell Cardiol       Date:  2017-07-05       Impact factor: 5.000

3.  Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles.

Authors:  Thomas Ravn Lassen; Jesper Just; Marie Vognstoft Hjortbak; Nichlas Riise Jespersen; Katrine Tang Stenz; Tingting Gu; Yan Yan; Junyi Su; Jakob Hansen; Rikke Bæk; Malene Møller Jørgensen; Jens Randel Nyengaard; Steen Buus Kristiansen; Kim Ryun Drasbek; Jørgen Kjems; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-03-10       Impact factor: 17.165

4.  Krebs cycle metabolites and preferential succinate oxidation following neonatal hypoxic-ischemic brain injury in mice.

Authors:  Prateek V Sahni; Jimmy Zhang; Sergey Sosunov; Alexander Galkin; Zoya Niatsetskaya; Anatoly Starkov; Paul S Brookes; Vadim S Ten
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

5.  Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model.

Authors:  Marie Vognstoft Hjortbak; Johanne Hjort; Jonas Agerlund Povlsen; Rebekka Vibjerg Jensen; Nicolaj Brejnholdt Støttrup; Mia R Laursen; Nichlas Riise Jespersen; Bo Løfgren; Hans Erik Bøtker
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.